Chemo-Pharma [CPL] vs Indef Manufacturing [BAJAJINDEF] Detailed Stock Comparison

Chemo-Pharma Laboratories Inc.

BSE
Loading...

Indef Manufacturing Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Chemo-Pharma Laboratories Inc. wins in 12 metrics, Indef Manufacturing Ltd. wins in 6 metrics, with 0 ties. Chemo-Pharma Laboratories Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Chemo-Pharma Laboratories Inc. Indef Manufacturing Ltd. Better
P/E Ratio (TTM) 13.22 35.59 Chemo-Pharma Laboratories Inc.
Price-to-Book Ratio 2.69 3.72 Chemo-Pharma Laboratories Inc.
Debt-to-Equity Ratio 48.02 1.57 Indef Manufacturing Ltd.
PEG Ratio 0.42 -0.63 Chemo-Pharma Laboratories Inc.
EV/EBITDA 13.60 41.90 Chemo-Pharma Laboratories Inc.
Profit Margin (TTM) 6.53% 13.98% Indef Manufacturing Ltd.
Operating Margin (TTM) 11.52% 5.29% Chemo-Pharma Laboratories Inc.
EBITDA Margin (TTM) 11.52% 5.29% Chemo-Pharma Laboratories Inc.
Return on Equity 20.97% 13.51% Chemo-Pharma Laboratories Inc.
Return on Assets (TTM) 11.26% 11.33% Indef Manufacturing Ltd.
Free Cash Flow (TTM) $41.66M $-39.71M Chemo-Pharma Laboratories Inc.
Dividend Yield N/A 0.47% N/A
1-Year Return -5.34% -45.26% Chemo-Pharma Laboratories Inc.
Price-to-Sales Ratio (TTM) 1.31 4.98 Chemo-Pharma Laboratories Inc.
Enterprise Value $5.40B $9.53B Indef Manufacturing Ltd.
EV/Revenue Ratio 1.52 4.95 Chemo-Pharma Laboratories Inc.
Gross Profit Margin (TTM) 24.93% 45.53% Indef Manufacturing Ltd.
Revenue per Share (TTM) $62 $60 Chemo-Pharma Laboratories Inc.
Earnings per Share (Diluted) $5.81 $8.43 Indef Manufacturing Ltd.
Beta (Stock Volatility) 0.28 N/A N/A

Chemo-Pharma Laboratories Inc. vs Indef Manufacturing Ltd. Stock Performance Analysis

Loading Price Chart...

CPL
BAJAJINDEF

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Chemo-Pharma Laboratories Inc.0.43%-0.20%-9.72%10.04%-11.06%-12.31%
Indef Manufacturing Ltd.-2.77%4.76%-15.00%1.38%-26.81%-34.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Chemo-Pharma Laboratories Inc.-5.34%232.23%82.57%325.71%1,271.09%1,271.09%
Indef Manufacturing Ltd.-45.26%-7.98%-7.98%-7.98%-7.98%-7.98%

Performance & Financial Health Analysis: Chemo-Pharma Laboratories Inc. vs Indef Manufacturing Ltd.

MetricCPLBAJAJINDEF
Market Information
Market Cap i₹4.62B₹10.00B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i97,70053,770
90 Day Avg. Volume i68,66153,079
Last Close₹70.50₹238.85
52 Week Range₹52.67 - ₹87.75₹207.25 - ₹580.25
% from 52W High-19.66%-58.84%
All-Time High₹128.00 (Jan 06, 2025)₹580.25 (Jul 04, 2025)
% from All-Time High-44.92%-58.84%
Growth Metrics
Quarterly Revenue Growth0.40%0.13%
Quarterly Earnings Growth0.41%-0.30%
Financial Health
Profit Margin (TTM) i0.07%0.14%
Operating Margin (TTM) i0.12%0.05%
Return on Equity (TTM) i0.21%0.14%
Debt to Equity (MRQ) i48.021.57
Cash & Liquidity
Book Value per Share (MRQ)₹28.58₹80.71
Cash per Share (MRQ)₹0.05₹1.08
Operating Cash Flow (TTM) i₹277.99M₹196.10M
Levered Free Cash Flow (TTM) i₹313.23M₹341.60M
Dividends
Last 12-Month Dividend Yield iN/A0.47%
Last 12-Month Dividend i₹0.00₹2.00

Valuation & Enterprise Metrics Analysis: Chemo-Pharma Laboratories Inc. vs Indef Manufacturing Ltd.

MetricCPL (Apr 26, 2026)BAJAJINDEF (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i13.2235.59
Forward P/E iN/AN/A
PEG Ratio i0.42-0.63
Price to Sales (TTM) i1.314.98
Price to Book (MRQ) i2.693.72
Market Capitalization
Market Capitalization i₹4.62B₹10.00B
Enterprise Value i₹5.40B₹9.53B
Enterprise Value Metrics
Enterprise to Revenue i1.524.95
Enterprise to EBITDA i13.6041.90
Risk & Other Metrics
Beta i0.28N/A
Book Value per Share (MRQ) i₹28.58₹80.71

Financial Statements Comparison: Chemo-Pharma Laboratories Inc. vs Indef Manufacturing Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCPL (2025)BAJAJINDEF (2025)
Revenue/Sales i2.85B1.77B
Cost of Goods Sold i2.07B1.05B
COGS % of Revenue i72.6%59.1%
Gross Profit i778.98M725.50M
Gross Margin i27.4%40.9%
Research & Development iN/AN/A
Operating Income (EBIT) i300.69M256.05M
Operating Margin i10.6%14.4%
EBITDA i353.29M331.16M
EBITDA Margin i12.4%18.7%
Pre-Tax Income i392.47M419.51M
Pre-Tax Income % of Revenue i13.8%23.6%
Income Tax i79.24M77.90M
Income Tax % of Revenue i2.8%4.4%
Net Income (Profit) i313.23M341.60M
Profit Margin i11.0%19.2%

Balance Sheet & Liquidity Metrics

MetricCPL (2025)BAJAJINDEF (2025)
Cash & Equivalents i12.05M55.19M
Total Current Assets i2.51B633.93M
Total Current Assets % of Revenue i88.1%35.7%
Total Current Liabilities i1.17B328.08M
Total Current Liabilities % of Revenue i41.2%18.5%
Long-Term Debt i109.50M20.75M
Long-Term Debt % of Revenue i3.8%1.2%
Total Shareholders Equity i1.49B2.53B
Retained Earnings i1.08B793.87M
Retained Earnings % of Revenue i37.9%44.7%
Property, Plant & Equipment i48.61M59.44M

Cash Flow Statement Comparison

MetricCPL (2025)BAJAJINDEF (2025)
Operating Cash Flow i277.99M196.10M
Operating Cash Flow % of Revenue i9.8%11.0%
Capital Expenditures i-47.82M-86.93M
Free Cash Flow i41.66M-39.71M
FCF Margin i1.5%-2.2%
Debt Repayment i-359.80MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPLBAJAJINDEF
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i60.18M32.00M
Float Shares i17.41M8.76M
% Held by Insiders i69.98%74.03%
% Held by Institutions i0.00%0.00%
% Held by Public i30.02%25.97%

Dividend Analysis & Yield Comparison: Chemo-Pharma Laboratories Inc. vs Indef Manufacturing Ltd.

MetricCPLBAJAJINDEF
Last 12-Month Dividend i₹0.00₹2.00
Last 12-Month Dividend Yield iN/A0.47%
3-Year Avg Annual Dividend i₹0.00₹0.67
3-Year Avg Dividend Yield iN/A0.47%
3-Year Total Dividends i₹0.00₹2.00
Ex-Dividend DateN/AAug 05, 2025